HRP20090022T3 - Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences - Google Patents

Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences

Info

Publication number
HRP20090022T3
HRP20090022T3 HR20090022T HRP20090022T HRP20090022T3 HR P20090022 T3 HRP20090022 T3 HR P20090022T3 HR 20090022 T HR20090022 T HR 20090022T HR P20090022 T HRP20090022 T HR P20090022T HR P20090022 T3 HRP20090022 T3 HR P20090022T3
Authority
HR
Croatia
Prior art keywords
fungal
treatment
ascorbic acid
superfinfections
recurrences
Prior art date
Application number
HR20090022T
Other languages
English (en)
Croatian (hr)
Inventor
Mailland Federico
Original Assignee
Polichem S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polichem S.A. filed Critical Polichem S.A.
Publication of HRP20090022T3 publication Critical patent/HRP20090022T3/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
HR20090022T 2003-07-22 2009-01-16 Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences HRP20090022T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03077314A EP1500394A1 (en) 2003-07-22 2003-07-22 Pharmaceutical compositions comprising ascorbic acid or the treatment of fungal superinfections and fungal recurrences
PCT/EP2004/005559 WO2005013971A1 (en) 2003-07-22 2004-05-21 Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences

Publications (1)

Publication Number Publication Date
HRP20090022T3 true HRP20090022T3 (en) 2009-02-28

Family

ID=33483977

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090022T HRP20090022T3 (en) 2003-07-22 2009-01-16 Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences

Country Status (23)

Country Link
US (1) US7863326B2 (pl)
EP (2) EP1500394A1 (pl)
JP (1) JP4791358B2 (pl)
KR (1) KR101100713B1 (pl)
CN (1) CN100540000C (pl)
AR (1) AR045070A1 (pl)
AT (1) ATE413171T1 (pl)
BR (1) BRPI0412453A (pl)
CA (1) CA2528879A1 (pl)
CY (1) CY1108684T1 (pl)
DE (1) DE602004017613D1 (pl)
DK (1) DK1646378T3 (pl)
EA (1) EA010241B1 (pl)
ES (1) ES2314406T3 (pl)
HK (1) HK1092693A1 (pl)
HR (1) HRP20090022T3 (pl)
MX (1) MXPA05013798A (pl)
PL (1) PL1646378T3 (pl)
PT (1) PT1646378E (pl)
SI (1) SI1646378T1 (pl)
UA (1) UA88446C2 (pl)
WO (1) WO2005013971A1 (pl)
ZA (1) ZA200509851B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007000662A2 (en) * 2005-02-03 2007-01-04 Taro Pharmaceuticals U.S.A., Inc. Novel propofol composition comprising ascorbic acid or pharmaceutically acceptable salts thereof
US20090197946A1 (en) * 2008-01-31 2009-08-06 Joseph Di Bartolomeo Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
CN102933713B (zh) * 2010-04-08 2015-05-13 佛罗里达大学研究基金会有限公司 具有多功能的瞬时表达病毒载体体系
DE102012009057A1 (de) 2012-05-09 2013-11-14 Dr. Arabin GmbH & Co. KG Rotationspessar mit zusätzlicher Wirkstoffkomponente
FR3018193B1 (fr) 2014-03-10 2017-09-08 Probionov Comprime vaginal muco-adhesif a liberation prolongee
US11865139B2 (en) * 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4229430A (en) * 1978-08-21 1980-10-21 Fahim Mostafa S Oral composition for improving oral health
JPH01125306A (ja) * 1987-11-09 1989-05-17 Daiichi Seimo Kk 赤腐れ菌の防除剤
EP0527241B1 (de) 1991-07-15 1994-03-16 Artesan Pharma Gesellschaft mit beschränkter Haftung Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich
US5425944A (en) * 1992-10-27 1995-06-20 Harich; Jakob Antimicrobial grapefruit extract
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
CN1245074A (zh) * 1998-04-26 2000-02-23 曾忠铭 减弱阴道酸度的药剂和用途
US6153635A (en) * 1998-11-20 2000-11-28 Upmalis; David H. Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
JP2000169370A (ja) * 1998-12-09 2000-06-20 Frontier:Kk 肉食動物用皮膚疾患治療薬及び健康食品
DE29900513U1 (de) * 1999-01-14 2000-08-10 Rst Icking Gmbh Schuh- bzw. Fuß-Hygienemittel
RU2150935C1 (ru) * 1999-06-22 2000-06-20 Московский государственный медико-стоматологический университет Защитно-профилактический крем
US6391330B1 (en) * 2000-05-11 2002-05-21 Michael A. Ross Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa
US20030130225A1 (en) * 2001-10-16 2003-07-10 Nawaz Ahmad Novel methods of treating local fungal and bacterial infections

Also Published As

Publication number Publication date
CY1108684T1 (el) 2014-04-09
KR101100713B1 (ko) 2011-12-30
BRPI0412453A (pt) 2006-10-17
DE602004017613D1 (de) 2008-12-18
SI1646378T1 (sl) 2009-02-28
ATE413171T1 (de) 2008-11-15
UA88446C2 (uk) 2009-10-26
US20070037880A1 (en) 2007-02-15
AR045070A1 (es) 2005-10-12
HK1092693A1 (en) 2007-02-16
CN1812781A (zh) 2006-08-02
CN100540000C (zh) 2009-09-16
KR20060040603A (ko) 2006-05-10
EP1646378B1 (en) 2008-11-05
CA2528879A1 (en) 2005-02-17
DK1646378T3 (da) 2009-01-19
JP2006528138A (ja) 2006-12-14
PL1646378T3 (pl) 2009-04-30
EP1500394A1 (en) 2005-01-26
PT1646378E (pt) 2008-12-17
WO2005013971A1 (en) 2005-02-17
ZA200509851B (en) 2007-03-28
EA010241B1 (ru) 2008-06-30
ES2314406T3 (es) 2009-03-16
EP1646378A1 (en) 2006-04-19
EA200600176A1 (ru) 2006-06-30
MXPA05013798A (es) 2006-06-27
JP4791358B2 (ja) 2011-10-12
US7863326B2 (en) 2011-01-04

Similar Documents

Publication Publication Date Title
HRP20090022T3 (en) Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences
EA200601654A1 (ru) Ингибиторы интегразы вич
LU92323I2 (fr) La combinaison de (a) dextromethorphan ou un de ses sels pharmaceutiquement acceptables, précursers ou dérivés, par ex. hydrobromure de dextromethorphan et en particulier hydrobromure de dextromethorphan monohydrate;et (b) quinidine ou un de ses selspharmacuetiquement acceptables, précurseurs ou dé rivés, par ex. sulfate de quinidine et en particulier sulfate de quinidine dihydrate
UA94901C2 (ru) Антибактериальные производные пиперидина
PE20020237A1 (es) Composicion oral topica
MXPA03005464A (es) Agentes antivirales.
WO2003053368A3 (en) Chalcone derivatives and their use to treat diseases
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
RS50937B (sr) Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii
SE9900961D0 (sv) Novel compounds
AU2003241345A1 (en) Use of mastic and its components for the control of microbial infections
MXPA03010761A (es) Combinaciones farmaceuticas.
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
ATE466008T1 (de) P-glycoprotein-inhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält
WO2003066597A3 (en) Guanidino compounds
WO2005026145A3 (en) Quinolone antibacterial agents
DE60131416D1 (de) Chirale fluorochinolizinon arginine salze
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
SE0001916D0 (sv) Novel formulation
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv